The distribution of erlotinib in tumours from xenograft mice subcutaneously implanted with B901L, an EGFR-mutated NSCLC cell line, and treated or not treated with bevacizumab, was analysed at various time points. Here, EGFR is linked to non-small cell lung carcinoma.